METHODS FOR ADMINISTERING LONG-LASTING HYPOGLYCEMIC AGENTS

Disclosed is a pharmaceutical composition comprising a sequence of tandem repeats of GLP-1l(7-36(A8G)) fused to human serum albumin. The composition is used in the manufacture of a medicament for treating a disease associated with elevated blood glucose selected from type 1 diabetes, type 2 diabetes...

Full description

Saved in:
Bibliographic Details
Main Authors BUSH, MARK, A, WALKER, SUSAN, E, MATTHEWS, JESSICA, E
Format Patent
LanguageEnglish
Published 25.11.2011
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a pharmaceutical composition comprising a sequence of tandem repeats of GLP-1l(7-36(A8G)) fused to human serum albumin. The composition is used in the manufacture of a medicament for treating a disease associated with elevated blood glucose selected from type 1 diabetes, type 2 diabetes, glucose intolerance, hypoglycemia and Alzheimer's disease.
Bibliography:Application Number: NZ20070575419